SavedAdd your journal

Journals / Turkish Journal of Clinics and Laboratory / 2017 / Cilt: 8 - Sayı: 1

Medical treatment of vertigo

Vertigonun medikal tedavisi

SERKAN TURSUN
GÖKÇE ŞİMŞEK
NURAY BAYAR MULUK
Pages
23–27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this section, medical treatment of vertigo will be described with mentioning of the current medications and their therapeutic doses available dosage in our country.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vertigo (dizziness), constitutes a common group of diseases not only in the practice of otolaryngology, also in the practice of family physicians.
📊
Key Findings & Data:There are various diseases in the etiology of this pathology and definitive diagnosis is not always possible.
💡
Conclusion & Impact:In this section, medical treatment of vertigo will be described with mentioning of the current medications and their therapeutic doses available dosage in our country.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Vertigo · medikal tedavi · Vertigo

Abstract

Vertigo (dizziness), constitutes a common group of diseases not only in the practice of otolaryngology, also in the practice of family physicians. There are various diseases in the etiology of this pathology and definitive diagnosis is not always possible. The primary objective in the treatment should be reduction of symptoms in the patients with acute attacks of vertigo. In this section, medical treatment of vertigo will be described with mentioning of the current medications and their therapeutic doses available dosage in our country.

Özet

Vertigo (baş dönmesi), sadece kulak burun boğaz değil, aile hekimliği pratiğinde de sık rastlanan bir hastalık grubunu oluşturmaktadır. Etyolojisinde çok çeşitli hastalıkların bulunduğu bu patolojinin kesin tanısı her zaman mümkün olamamaktadır. Tedavide öncelikli amaç, akut vertigo atağı ile gelen hastanın semptomlarının azaltılması olmalıdır. Vertigonun medikal tedavisinin anlatılacağı bu bölümde ülkemizdeki mevcut ilaçlar ve tedavi dozlarından da bahsedilecektir.

🔖

Cite This Article

TURSUN, S., ŞİMŞEK, G., MULUK, N. B. (2017). Medical treatment of vertigo. Turkish Journal of Clinics and Laboratory, Cilt: 8 - Sayı: 1, 23–27. https://ajindex.com/articles/372854

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ciuman RR. Inner ear symptoms and disease: Pathophysiological understanding and therapeutic options. Med Sci Monit 2013; 19: 1195-210.
  2. Huh YE, Kim JS. Bedside evaluation of dizzy patients. J Clin Neurol 2013; 9: 203-13.
  3. Zanni GR, Wick JY. Vertigo: few new spins on a common problem. Consult Pharm 2006; 21: 680-96.
  4. Sajjadi H, Paparella MM. Meniere's disease. Lancet 2008; 372: 406-14. Vademecum 2013 modern ilaç rehberi, 35.baskı, Nobel kitabevi. Zajonc TP, Roland PS. Vertigo and motion sickness. Part II: Pharmacologic treatment. Ear Nose Throat J 2006; 85: 25-35.
  5. Renner UD, Oertel R, Kirch W. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit 2005; 27: 655-65.
  6. Lin E, Aligene K. Pharmacology of balance and dizziness. NeuroRehabilitation 2013; 32: 529-42.
  7. Huppert D, Strupp M, Mückter H, Brandt T. Which medication do I need to manage dizzy patients? Acta Otolaryngol 2011; 131: 228-41.
  8. Venail F, Biboulet R, Mondain M, Uziel A. A protective effect of 5-HT3 antagonist against vestibular deficit? Metoclopramide versus ondansetron at the early stage of vestibular neuritis: a pilot study. Eur Ann Otorhinolaryngol Head Neck Dis 2012; 129: 65-8.
  9. Della Pepa C, Guidetti G, Eandi M. Betahistine in the treatment of vertiginous syndromes: a meta-analysis. Acta Otorhinolaryngol Ital 2006; 26: 208-15. Nauta JJ. Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo. Eur Arch Otorhinolaryngol 201; 217: 887-97.
  10. Mukhopadhyay S, Niyogi M, Ray R, Mukhopadhyay BS, Dutta M, Mukherjee M. Betahistine as an add-on: The magic bullet for postoperative nausea, vomiting and dizziness after middle ear surgery? J Anaesthesiol Clin Pharmacol 2013; 29: 205-10.
  11. James AL, Thorp MA. Menière's disease. Clin Evid (Online). 2007 Mar 1; 2007. pii: 0505. Orhan I, Aydın S, Altın G, Yılmaz F. An efficacy comparison of betahistin, trimetazidine and ginkgo biloba extract in patients with tinnitus. Kulak Burun Bogaz Ihtis Derg 2013; 23: 143-7.
  12. Lepcha A, Amalanathan S, Augustine AM, Tyagi AK, Balraj A. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol 2014; 271: 2931-6.
  13. Cesarani A, Meloni F, Alpini D, Barozzi S, Verderio L, Boscani PF. Ginkgo biloba (EGb 761) in the treatment of equilibrium disorders. Adv Ther 1998; 15: 291-304.
  14. Diamond BJ, Shiflett SC, Feiwel N, et al. Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil 2000; 81: 668-78. Maclen